Syria’s First Lady To Withdraw From Public Duty To Treat Leukaemia – Presidency
Joy ChukwuMay 21, 20241 Mins read893 
Asma al-Assad, Syria’s first lady, has been diagnosed with leukaemia, the Syrian presidency announced in a statement on Tuesday.
“First Lady Asma al-Assad has been diagnosed with acute myeloid leukaemia,” the statement read.
It revealed that she “will undergo a specialised treatment protocol” that requires social distancing to avoid infection, adding that she will “temporarily withdraw from all direct engagements as part of her treatment plan”.
Acute myeloid leukaemia is an aggressive cancer of the bone marrow and the blood.
Assad has previously been treated for breast cancer. In August 2019, she announced that she was “completely” free of the disease a year after her diagnosis.
About The Author
Related Articles
CBN Hikes ATM Card Issuance Fee by 50 Percent to N1,500, Scraps Monthly Maintenance Charge
The Central Bank of Nigeria has increased the fee for the issuance...
Tinubu’s Debt Relief Fails to Avert New Seven Day Shutdown Warning from Nigerian Airlines
Despite the approval of a 30 percent debt discount for domestic airlines...
Tinubu’s Financial Strategy for 2027 Elections, Borrow $516m, Hide ₦17bn in Wards, and Keep ₦135bn for the Lawyers
President Bola Tinubu has formally written to the Senate seeking approval to...
Nigerians See the Truth, Tinubu’s ₦17 Billion Ward Money Is a Vote Buying Slush Fund
President Bola Tinubu has approved a ₦17 billion Community-Based National Social Action...